DEA Shuts Down Drug Factory Even as Adderall Shortage Persists
The DEA is cracking down on manufacturers, hurting patients who genuinely need those drugs.
The DEA is cracking down on manufacturers, hurting patients who genuinely need those drugs.
The change, while welcome, is modest and won't get rid of patients' headaches as they try to fill their prescriptions.
While schoolchildren go without needed medication, government agencies shirk responsibility by blaming manufacturers.
Each year, the DEA sets production limits for certain drugs, including some ingredients in common amphetamine pills like Adderall.
On Friday, the DEA unveiled a plan to restrict doctors' ability to prescribe controlled drugs over telehealth.
Limiting the supply of a controlled substance does not remove demand. Users simply look elsewhere, including more unsavory sources.